Is colorectal cancer a more aggressive disease in young
patients? A population-based study from the Czech Republic

J 2019

Is colorectal cancer a more aggressive disease in young patients? A population-based study from the Czech Republic

KOCIAN, Petr; Ivana SVOBODOVÁ; Denisa KREJČÍ; Milan BLAHA; Robert GURLICH et al.

Základní údaje

Originální název

Is colorectal cancer a more aggressive disease in young patients? A population-based study from the Czech Republic

Autoři

KOCIAN, Petr; Ivana SVOBODOVÁ; Denisa KREJČÍ; Milan BLAHA; Robert GURLICH; Ladislav DUŠEK; Jiri HOCH a Adam WHITLEY

Vydání

Cancer epidemiology, Oxford, Elsevier, 2019, 1877-7821

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.179

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/19:00112407

Organizační jednotka

Lékařská fakulta

DOI

https://doi.org/10.1016/j.canep.2019.101621

UT WoS

000504659600021

EID Scopus

2-s2.0-85073504002

Klíčová slova anglicky

Colorectal cancer; Age; Survival; Population study; Epidemiology

Štítky

14119612, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 15. 1. 2020 14:40, Mgr. Tereza Miškechová

Anotace

V originále

Introduction: The incidence of colorectal cancer in young patients is increasing. The goal of this study was to investigate whether clinicopathological features and survival differed between young, middle-aged and elderly patients. Methods: The Czech National Cancer Registry was searched to identify all cases of colorectal cancer between 1982 and 2014. Three subgroups of patients were created: young patients, defined as being between 18 and 40 years of age, middle-aged patients, defined as being between 41 and 74 years of age, and elderly patients, defined as being over the age of 75 years. Results: A total of 192,241 patients diagnosed with colorectal cancer between the years 1982 and 2014 were included in the study. Out of these, 3,287 patients (1.7%) were between 18 and 40 years of age, 134,139 patients (69.8%) were between 41 and 74 years of age and 54,815 patients (28.5%) were 75 years of age or older. The young patients had a higher incidence of mucinous adenocarcinoma and signet ring cell carcinoma, more advanced disease and more rectal tumours than elderly patients. Nonetheless, young patients received treatment more frequently and had better cancer-specific survival than the older patients. Conclusion: The better prognosis in young patients is presumably due to their better physiological reserve and lower incidence of comorbidities. Efforts should be made in younger patients to diagnose early and treat aggressively.

Citovat

KOCIAN, Petr; Ivana SVOBODOVÁ; Denisa KREJČÍ; Milan BLAHA; Robert GURLICH; Ladislav DUŠEK; Jiri HOCH a Adam WHITLEY. Is colorectal cancer a more aggressive disease in young patients? A population-based study from the Czech Republic. Cancer epidemiology. Oxford: Elsevier, 2019, roč. 63, DEC 2019, s. 1-7. ISSN 1877-7821. Dostupné z: https://doi.org/10.1016/j.canep.2019.101621.

@article{1604518,
   author = {Kocian, Petr and Svobodová, Ivana and Krejčí, Denisa and Blaha, Milan and Gurlich, Robert and Dušek, Ladislav and Hoch, Jiri and Whitley, Adam},
   article_location = {Oxford},
   article_number = {DEC 2019},
   doi = {https://doi.org/10.1016/j.canep.2019.101621},
   keywords = {Colorectal cancer; Age; Survival; Population study; Epidemiology},
   language = {eng},
   issn = {1877-7821},
   journal = {Cancer epidemiology},
   title = {Is colorectal cancer a more aggressive disease in young patients? A population-based study from the Czech Republic},
   url = {http://dx.doi.org/10.1016/j.canep.2019.101621},
   volume = {63},
   year = {2019}
}

TY  - JOUR
ID  - 1604518
AU  - Kocian, Petr - Svobodová, Ivana - Krejčí, Denisa - Blaha, Milan - Gurlich, Robert - Dušek, Ladislav - Hoch, Jiri - Whitley, Adam
PY  - 2019
TI  - Is colorectal cancer a more aggressive disease in young patients? A population-based study from the Czech Republic
JF  - Cancer epidemiology
VL  - 63
IS  - DEC 2019
SP  - 1-7
EP  - 1-7
PB  - Elsevier
SN  - 18777821
KW  - Colorectal cancer
KW  - Age
KW  - Survival
KW  - Population study
KW  - Epidemiology
UR  - http://dx.doi.org/10.1016/j.canep.2019.101621
L2  - http://dx.doi.org/10.1016/j.canep.2019.101621
N2  - Introduction: The incidence of colorectal cancer in young patients is increasing. The goal of this study was to investigate whether clinicopathological features and survival differed between young, middle-aged and elderly patients. Methods: The Czech National Cancer Registry was searched to identify all cases of colorectal cancer between 1982 and 2014. Three subgroups of patients were created: young patients, defined as being between 18 and 40 years of age, middle-aged patients, defined as being between 41 and 74 years of age, and elderly patients, defined as being over the age of 75 years. Results: A total of 192,241 patients diagnosed with colorectal cancer between the years 1982 and 2014 were included in the study. Out of these, 3,287 patients (1.7%) were between 18 and 40 years of age, 134,139 patients (69.8%) were between 41 and 74 years of age and 54,815 patients (28.5%) were 75 years of age or older. The young patients had a higher incidence of mucinous adenocarcinoma and signet ring cell carcinoma, more advanced disease and more rectal tumours than elderly patients. Nonetheless, young patients received treatment more frequently and had better cancer-specific survival than the older patients. Conclusion: The better prognosis in young patients is presumably due to their better physiological reserve and lower incidence of comorbidities. Efforts should be made in younger patients to diagnose early and treat aggressively.
ER  -

KOCIAN, Petr; Ivana SVOBODOVÁ; Denisa KREJČÍ; Milan BLAHA; Robert GURLICH; Ladislav DUŠEK; Jiri HOCH a Adam WHITLEY. Is colorectal cancer a more aggressive disease in young patients? A population-based study from the Czech Republic. \textit{Cancer epidemiology}. Oxford: Elsevier, 2019, roč.~63, DEC 2019, s.~1-7. ISSN~1877-7821. Dostupné z: https://doi.org/10.1016/j.canep.2019.101621.

Přehled o publikaci